US SB4875 | 2025-2026 | 119th Congress
Status
Sponsorship: Bipartisan Bill
Status: Introduced on June 23 2026 - 25% progression
Action: 2026-06-23 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 23 2026 - 25% progression
Action: 2026-06-23 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes.
Title
PASTEUR Act of 2026 Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2026
Sponsors
| Sen. Michael Bennet [D-CO] | Sen. Todd Young [R-IN] | Sen. Kirsten Gillibrand [D-NY] | Sen. Mike Rounds [R-SD] |
| Sen. John Hickenlooper [D-CO] |
History
| Date | Chamber | Action |
|---|---|---|
| 2026-06-23 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB7352 (Same As) 2026-02-04 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/119th-congress/senate-bill/4875/all-info |
| Text | https://www.congress.gov/119/bills/s4875/BILLS-119s4875is.pdf |
